Literature DB >> 8463345

Expression of human platelet glycoprotein Ib alpha in transgenic mice.

J Ware1, S R Russell, P Marchese, Z M Ruggeri.   

Abstract

Platelets are cytoplasmic fragments of megakaryocytes and, therefore, their membrane proteins cannot be manipulated by expression methods in culture. To overcome this limitation, we have expressed human glycoprotein (GP) Ib alpha in transgenic mouse megakaryocytes and found that it was present on the surface of platelets associated with the mouse GP Ib beta subunit. This finding demonstrates that assembly of the heterooligomeric GP Ib complex occurs through mechanisms conserved across species. In contrast, the receptor function of GP Ib exhibited restricted species specificity, since only the chimeric complex containing human GP Ib alpha bound human von Willebrand factor and supported platelet aggregation mediated by ristocetin. These studies demonstrate the transgenic engineering of a platelet adhesion receptor under control of the human GP Ib alpha promoter and illustrate a new approach to manipulate platelet receptors and study structure-function relationships in hemostasis and thrombosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8463345

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  A model for studying megakaryocyte development and biology.

Authors:  G J Murphy; A D Leavitt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome.

Authors:  J Ware; S Russell; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  High shear-dependent loss of membrane integrity and defective platelet adhesion following disruption of the GPIbα-filamin interaction.

Authors:  Susan L Cranmer; Katrina J Ashworth; Yu Yao; Michael C Berndt; Zaverio M Ruggeri; Robert K Andrews; Shaun P Jackson
Journal:  Blood       Date:  2010-12-14       Impact factor: 22.113

Review 4.  Humanizing thrombi in mice.

Authors:  Jorge Magallon; Matthew Egalka; Thomas G Diacovo
Journal:  Trends Cardiovasc Med       Date:  2011-01       Impact factor: 6.677

Review 5.  Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib.

Authors:  Zaverio M Ruggeri; Alessandro Zarpellon; James R Roberts; Richard A Mc Clintock; Hua Jing; G Loredana Mendolicchio
Journal:  Thromb Haemost       Date:  2010-10-12       Impact factor: 5.249

6.  Humanized GPIbα-von Willebrand factor interaction in the mouse.

Authors:  Sachiko Kanaji; Jennifer N Orje; Taisuke Kanaji; Yuichi Kamikubo; Yosuke Morodomi; Yunfeng Chen; Alessandro Zarpellon; Jerome Eberhardt; Stefano Forli; Scot A Fahs; Rashmi Sood; Sandra L Haberichter; Robert R Montgomery; Zaverio M Ruggeri
Journal:  Blood Adv       Date:  2018-10-09

7.  Defective Association of the Platelet Glycoprotein Ib-IX Complex with the Glycosphingolipid-Enriched Membrane Domain Inhibits Murine Thrombus and Atheroma Formation.

Authors:  Hao Zhou; Yali Ran; Qi Da; Tanner S Shaw; Dan Shang; Anilkumar K Reddy; José A López; Christie M Ballantyne; Jerry Ware; Huaizhu Wu; Yuandong Peng
Journal:  J Immunol       Date:  2016-05-20       Impact factor: 5.422

8.  Dimerization of glycoprotein Ibα is not sufficient to induce platelet clearance.

Authors:  X Liang; A K Syed; S R Russell; J Ware; R Li
Journal:  J Thromb Haemost       Date:  2016-01-30       Impact factor: 5.824

9.  Antioxidant prevents clearance of hemostatically competent platelets after long-term cold storage.

Authors:  Shailaja Hegde; Ashley M Wellendorf; Yi Zheng; Jose A Cancelas
Journal:  Transfusion       Date:  2020-11-27       Impact factor: 3.157

10.  Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease.

Authors:  Larry J Suva; Eric Hartman; Joshua D Dilley; Susan Russell; Nisreen S Akel; Robert A Skinner; William R Hogue; Ulrich Budde; Kottayil I Varughese; Taisuke Kanaji; Jerry Ware
Journal:  Am J Pathol       Date:  2008-01-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.